A Role for MAIT Cells in Colorectal Cancer.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 19 02 2020
accepted: 22 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 30 3 2021
Statut: epublish

Résumé

MAIT cells are MR1-restricted T cells that are well-known for their anti-microbial properties, but they have recently been associated with different forms of cancer. Several studies have reported activated MAIT cells within the microenvironment of colorectal tumors, but there is conjecture about the nature of their response and whether they are contributing to anti-tumor immunity, or to the progression of the disease. We have reviewed the current state of knowledge about the role of MAIT cells in colorectal cancer, including their likely influence when activated and potential sources of stimulation in the tumor microenvironment. The prospects for MAIT cells being used in clinical settings as biomarkers or as targets of new immunotherapies designed to harness their function are discussed.

Identifiants

pubmed: 32508830
doi: 10.3389/fimmu.2020.00949
pmc: PMC7251153
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

949

Informations de copyright

Copyright © 2020 Berzins, Wallace, Kannourakis and Kelly.

Références

Front Immunol. 2018 Jun 28;9:1478
pubmed: 30013556
Front Oncol. 2016 Apr 19;6:96
pubmed: 27148488
Int Immunol. 2008 Dec;20(12):1517-25
pubmed: 18927318
Oncotarget. 2016 Nov 15;7(46):76274-76290
pubmed: 27517754
Sci Rep. 2016 Feb 03;6:20358
pubmed: 26837580
J Pathol. 2006 May;209(1):121-8
pubmed: 16482497
Science. 2015 Apr 3;348(6230):80-6
pubmed: 25838377
Annu Rev Immunol. 2014;32:323-66
pubmed: 24499274
PLoS Biol. 2009 Mar 10;7(3):e54
pubmed: 19278296
World J Gastroenterol. 2014 Jan 28;20(4):908-22
pubmed: 24574765
Int J Cancer. 1999 Jun 21;84(3):326-30
pubmed: 10371355
Cell Rep. 2019 Sep 17;28(12):3077-3091.e5
pubmed: 31533032
Immunity. 2018 Mar 20;48(3):453-473
pubmed: 29562195
Science. 2019 Jan 4;363(6422):
pubmed: 30523076
J Immunol. 2015 Oct 1;195(7):3472-81
pubmed: 26297765
Cancer Immunol Immunother. 2017 Dec;66(12):1563-1575
pubmed: 28798979
Immunol Cell Biol. 2018 Jul;96(6):630-641
pubmed: 29350807
J Immunol. 2018 Mar 15;200(6):1995-2003
pubmed: 29431692
Mucosal Immunol. 2015 Nov;8(6):1226-36
pubmed: 25736457
Sci Immunol. 2019 Nov 15;4(41):
pubmed: 31732518
Scand J Immunol. 2014 Dec;80(6):462-3
pubmed: 25196940
Cent Eur J Immunol. 2019;44(1):75-83
pubmed: 31114440
Immunol Cell Biol. 2019 Sep;97(8):689-699
pubmed: 31323167
Front Immunol. 2017 Dec 15;8:1837
pubmed: 29326714
Scand J Immunol. 2014 Oct;80(4):271-5
pubmed: 24846411
Nature. 2012 Nov 8;491(7423):254-8
pubmed: 23034650
Gut. 2012 Dec;61(12):1765-73
pubmed: 22942239
Oncotarget. 2019 Apr 19;10(29):2810-2823
pubmed: 31073372
Ann Rheum Dis. 2016 Dec;75(12):2124-2132
pubmed: 27165176
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5434-E5443
pubmed: 28630305
Oncotarget. 2016 Sep 20;7(38):61183-61198
pubmed: 27533463
Clin Cancer Res. 2019 Jun 1;25(11):3304-3316
pubmed: 30723143
Nat Immunol. 2016 Nov;17(11):1300-1311
pubmed: 27668799
Adv Exp Med Biol. 2020;1224:63-77
pubmed: 32036605
Expert Opin Biol Ther. 2018 May;18(5):561-573
pubmed: 29471676
Cancer Immunol Immunother. 2018 Dec;67(12):1885-1896
pubmed: 29470597
Immunity. 2013 Jan 24;38(1):187-97
pubmed: 23260195
Nature. 2012 Nov 29;491(7426):717-23
pubmed: 23051753
Science. 2019 Oct 25;366(6464):
pubmed: 31649166
Nat Immunol. 2020 Feb;21(2):178-185
pubmed: 31959982
Eur J Immunol. 2014 Jan;44(1):195-203
pubmed: 24019201
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21
pubmed: 27848962
Cancer Res. 2011 Feb 15;71(4):1263-71
pubmed: 21303976
World J Gastroenterol. 2016 Jul 28;22(28):6362-72
pubmed: 27605872
Nat Rev Immunol. 2011 Jan;11(1):9-20
pubmed: 21151034
Nat Rev Cancer. 2013 Nov;13(11):759-71
pubmed: 24154716
Semin Immunol. 2017 Aug;32:43-53
pubmed: 28982615
Immunology. 2016 May;148(1):1-12
pubmed: 26778581
Immunol Cell Biol. 2018 Jul;96(6):573-587
pubmed: 29656544
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11513-E11522
pubmed: 30442667
PLoS Biol. 2010 Jun 29;8(6):e1000407
pubmed: 20613858
Adv Immunol. 2015;127:145-201
pubmed: 26073984
Nat Immunol. 2019 Sep;20(9):1110-1128
pubmed: 31406380
Cancer Immunol Immunother. 2015 Dec;64(12):1601-8
pubmed: 26497850
Sci Rep. 2018 Mar 7;8(1):4159
pubmed: 29515123
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Nature. 2014 May 15;509(7500):361-5
pubmed: 24695216
Nat Immunol. 2015 Nov;16(11):1114-23
pubmed: 26482978
Cell Rep. 2019 Sep 17;28(12):3249-3262.e5
pubmed: 31533045
Blood. 2011 Jan 27;117(4):1250-9
pubmed: 21084709

Auteurs

Stuart P Berzins (SP)

Fiona Elsey Cancer Research Institute, Ballarat, VIC, Australia.
Federation University Australia, Mount Helen, VIC, Australia.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.

Morgan E Wallace (ME)

Fiona Elsey Cancer Research Institute, Ballarat, VIC, Australia.
Federation University Australia, Mount Helen, VIC, Australia.

George Kannourakis (G)

Fiona Elsey Cancer Research Institute, Ballarat, VIC, Australia.
Federation University Australia, Mount Helen, VIC, Australia.

Jason Kelly (J)

Fiona Elsey Cancer Research Institute, Ballarat, VIC, Australia.
Federation University Australia, Mount Helen, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH